Vascular disease ultimately affects every organ in the human body. The treatment of vascular disease whether it involves the heart, brain, periphery and every other organ in the body has been steadily evolving from traditional surgery to more minimally invasive endovascular techniques. Advances in endovascular technology have already fundamentally altered the way we treat coronary artery disease, cerebral aneurysms, carotid stenosis, abdominal aortic aneurysms among numerous other disease processes.
Simultaneously, medical training of students, residents, fellows and physicians has been undergoing a transformation as the “see one, do one, teach one” model has become obsolete. The acquisition of good clinical judgement is derived from experience with difficult scenarios frequently resulting from complications during procedures and this experience is often preceded by poor clinical judgement. For surgeons, interventionists or any proceduralist there is a cost to acquiring a level of expertise that is considered mastery. This cost is the collateral damage in human quality of life.
A New Paradigm for Endovascular Training
Vascular Simulations LLC strives to reduce this collateral damage by physically replicating the vascular system from the heart to the aorta, cerebrovasculature and the peripheral vasculature. This replicator allows for the performance of endovascular procedures under real life fluoroscopic conditions with the actual access devices and implants that are utilized in clinical settings. It is fundamentally different than the current generation of endovascular simulators that model the performance and behavior of wires and catheters with computer software in a user interface that has no relevance to clinical procedures. These simulators are essentially glorified video games.
Vascular Simulations LLC is a limited liability company founded by Dr. Henry Woo MD, Michael Lockhart, Dr Baruch Lieber PhD, Dr David Fiorella MD PhD, Dr Chander Sadasivan PhD, and the Victoria Fund LLC. The manufacture of the replicators and all product development is accomplished at the Long Island Technology Incubator in Stony Brook, NY.